The absence of a retatrutide Summary of Product Characteristics (SmPC) on the Electronic Medicines Compendium (emc) further confirms its unlicensed status in the UK
Product identity, sterility, storage, dosing accuracy, and medical oversight all matter, especially for products promoted for injection
Those metabolic effects change the balance of estrogen and progesterone because fat tissue stores and metabolizes sex hormones, and because insulin signals directly influence ovarian function, especially in people with PCOS
If you are considering switching from semaglutide to tirzepatide, these same management strategies apply during the transition period
An estimated timeline of results is: Weeks 46 shows a reduction in shedding Weeks 812 reveals new visible growth Months 36 show significant density improvements After 6 months continued gains are sustained with ongoing therapy Side Effects and Safety Considerations Peptide treatments are generally well-tolerated and have a favorable safety profile compared to traditional hair loss drugs